Moderna (MRNA)
(Delayed Data from NSDQ)
$107.97 USD
+1.79 (1.69%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $107.85 -0.12 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Revenue: Product sales
- 6,671.00
- 18,435.00
- 17,675.00
- 200.00
- --
- Revenue - Line of Business (LOBR)
- Revenue: Other revenue
- 177.00
- 828.00
- 796.00
- --
- --
- Revenue - Line of Business (LOBR)
- Revenue: Collaboration revenue
- 83.00
- --
- 61.00
- 74.62
- 48.04
- Revenue - Line of Business (LOBR)
- Revenue: Grant revenue
- 94.00
- --
- 735.00
- 528.91
- 12.17
- Revenue - Line of Business (LOBR)
- Revenue: Collaboration revenue: Vertex
- 82.00
- 48.00
- 26.00
- 15.00
- --
- Revenue - Line of Business (LOBR)
- Revenue: Grant revenue: BARDA
- 88.00
- --
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Revenue: Grant revenue: Other
- 6.00
- 16.00
- 22.00
- 7.00
- --
- Revenue - Geographic (GEOR)
- Product sales: United States
- 1,720.00
- 5,150.00
- 6,177.00
- 764.00
- 60.00
- Revenue - Geographic (GEOR)
- Product sales: Europe
- 1,353.00
- 6,815.00
- 6,846.00
- 33.00
- --
- Revenue - Geographic (GEOR)
- Product sales: Rest of world
- 3,598.00
- 7,298.00
- 5,448.00
- 6.00
- --